Skip to main content

News

Latest News

Senior scientists with NSRI Aimee Ketner (left) and Zachary Minter (middle) get an overview of the new Eppendorf BioFlo® 610 fermentation system from BPDF GMP coordinator Scott Johnson.

Biological Process Development facility connects research to industry

February 6, 2026

The Biological Process Development Facility is working with an emerging biotechnology company on a vaccine that could both treat patients who have the novel coronavirus and help prevent similar outbreaks in the future.

Engineering facility aids COVID-19 vaccine development

June 8, 2020

The Biological Process Development Facility is working with an emerging biotechnology company on a vaccine that could both treat patients who have the novel coronavirus and help prevent similar outbreaks in the future.

Engineering facility producing therapeutic for COVID-19 patients

May 13, 2020

Wallace Buchholz, BPDF director and research professor of chemical and biomolecular engineering.

BPDF researchers part of team working on cyberbiosecurity issues for Defense Dept.

February 9, 2017

Amunix Establishes GMP Manufacturing of XTEN® at UNL BPDF

November 16, 2015

A member of UNL's Biological Process Development Facility examines equipment in 2012. The facility, located in Othmer Hall, has created a cream with the potential to block HIV transmission in women.

UNL facility produces compound for cream that may block HIV transmission

July 1, 2014